AstraZeneca has committed to reactivating a £200 million investment at its Cambridge headquarters, alongside a new £100 million funding initiative for its site in Macclesfield. This decision comes in the
All posts tagged in UK healthcare
17Articles
In a significant move for the burgeoning psychedelic industry, President Trump signed an executive order aimed at expediting the review of psychedelic therapies, as well as increasing federal research funding.
The involvement of Palantir Technologies in the UK’s National Health Service (NHS) has sparked widespread protests from campaigners. Recently, demonstrators gathered to voice their concerns over the firm’s significant influence
Patients suffering from end stage heart failure in the United Kingdom have been given renewed hope due to an innovative and cost effective stem cell therapy led by researchers at
Glioblastoma has long stood as one of the deadliest forms of brain cancer in the United Kingdom, with about 3200 cases diagnosed each year. Survival rates remain grim, as the
The landscape of prostate cancer diagnosis is on the cusp of transformation as the NHS introduces rapid new trials deploying artificial intelligence. Men presenting with possible symptoms of prostate cancer
Latest figures reveal a dramatic increase in the number of Britons opting for medical treatment abroad, spurred by mounting NHS waiting lists and ongoing concerns about accessibility within the UK
A bionic eye implant has delivered unprecedented results for sufferers of age-related macular degeneration (AMD), reigniting hope for hundreds of thousands facing blindness. Developed by Science Corporation, the Prima system
Sir Keir Starmer is preparing to overhaul NHS value for money protocols in a high-stakes move that could see Britain pour billions more into pharmaceutical spending. This comes amid escalating
Bristol Myers Squibb BMS has issued a pointed demand for the NHS to fund a greater share of pharmaceutical innovation calling for the UK to pay what it describes as
The battle between the NHS and pharmaceutical giants is reaching boiling point as accusations fly over the UK’s approach to funding modern medicines. A fresh row has ignited during President
The United Kingdom stands on the threshold of a radical transformation in obesity treatment, as Eli Lilly prepares to introduce a daily weight-loss pill, Orforglipron, in 2026, once regulatory approval
In a significant development for the healthcare technology sector, Apple’s AirPods Pro 2, have received approval to function as clinical-grade hearing aids in the UK market. This breakthrough comes following
In a significant move to address one of Britain’s most challenging political issues, the UK government has appointed Baroness Louise Casey to spearhead a four-year, cross-party task force examining the
British officials are studying pricing models for NHS patient data as part of an ambitious scheme to streamline information sales to companies and researchers. The initiative forms a crucial component
The aggressive marketing of weight-loss injections to British consumers has sparked significant concern amongst healthcare experts, who are witnessing what they describe as a “wild west” approach to pharmaceutical promotion.
- 1
- 2
